• 1
    Pyörälä K, Salonen JT, Valkonen T. Trends in coronary heart disease mortality and morbidity and related factors in Finland. Cardiology 1985; 72: 3551.
  • 2
    Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994; 90: 583612.
  • 3
    Keys A, Aravanis C, Blackburn H et al. Epidemiological studies related to coronary heart disease: characteristics of men aged 40–59 in seven countries. Acta Med Scand 1966; (Suppl. 460): 1392.
  • 4
    Vartiainen E, Jousilahti P, Alfthan G, Sundvall J, Pietinen P, Puska P. Cardiovascular risk factor changes in Finland, 1972–1997. Int J Epidemiol 2000; 29: 4956.
  • 5
    Jousilahti P, Vartiainen E, Pekkanen J, Tuomilehto J, Sundvall J, Puska P. Serum cholesterol distribution and coronary heart disease risk: observations and predictions among middle-aged population in eastern Finland. Circulation 1998; 97: 108794.
  • 6
    Vartiainen E, Puska P, Pekkanen J, Tuomilehto J, Jousilahti P. Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. BMJ 1994; 309: 237.
  • 7
    Vartiainen E, Laatikainen T, Tapanainen H et al.Suomalaisten sydän-ja verisuoritautien riskitekijät FINRISKI-tutkimuksessa 1982–2002. Suomen Lääkärilehti 2003; 58: 4099106.
  • 8
    Porkka KV, Raitakari OT, Leino A et al. Trends in serum lipid levels during 1980–1992 in children and young adults. The Cardiovascular Risk in Young Finns Study. Am J Epidemiol 1997; 146: 6477.
  • 9
    Evans A, Tolonen H, Hense HW, Ferrario M, Sans S, Kuulasmaa K. Trends in coronary risk factors in the WHO MONICA project. Int J Epidemiol 2001; 30 (Suppl. 1): S35S40.
  • 10
    Derby CA, Feldman HA, Bausserman LL, Parker DR, Gans KM, Carleton RA. HDL cholesterol: trends in two southeastern New England communities, 1981–1993. Ann Epidemiol 1998; 8: 8491.
  • 11
    Berns MA, de Vries JH, Katan MB. Increase in body fatness as a major determinant of changes in serum total cholesterol and high density lipoprotein cholesterol in young men over a 10-year period. Am J Epidemiol 1989; 130: 110922.
  • 12
    Salomaa V, Miettinen H, Kuulasmaa K et al. Decline of coronary heart disease mortality in Finland during 1983 to 1992: roles of incidence, recurrence, and case-fatality. The FINMONICA MI Register Study. Circulation 1996; 94: 31307.
  • 13
    Jousilahti P, Vartiainen E, Tuomilehto J, Pekkanen J, Puska P. Role of known risk factors in explaining the difference in the risk of coronary heart disease between eastern and southwestern Finland. Ann Med 1998; 30: 4817.
  • 14
    Åkerblom HK, Viikari J, Uhari M et al. Atherosclerosis precursors in Finnish children and adolescents. I. General description of the cross-sectional study of 1980, and an account of the children's and families’ state of health. Acta Paediatr Scand Suppl 1985; 318: 4963.
  • 15
    Viikari JS, Åkerblom HK, Nikkari T et al. Multicenter study of atherosclerosis precursors in Finnish children – pilot study of 8-year-old boys. Ann Clin Res 1982; 14: 10310.
  • 16
    Åkerblom H, Viikari J, Uhari M et al. A study of cardiovascular risk factors and their determinants in Finnish children. Ann Clin Res 1984; 16: 2333.
  • 17
    Kostner GM. Letter: enzymatic determination of cholesterol in high-density lipoprotein fractions prepared by polyanion precipitation. Clin Chem 1976; 22: 695.
  • 18
    Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499502.
  • 19
    Viikari J, Rönnemaa T, Seppänen A et al. Serum lipids and lipoproteins in children, adolescents and young adults in 1980–1986. Ann Med 1991; 23: 539.
  • 20
    Tunstall-Pedoe H, Kuulasmaa K, Mähönen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 1999; 353: 154757.
  • 21
    Pietinen P, Lahti-Koski M, Vartiainen E, Puska P. Nutrition and cardiovascular disease in Finland since the early 1970s: a success story. J Nutr Health Aging 2001; 5: 1504.
  • 22
    Pietinen P, Vartiainen E, Seppänen R, Aro A, Puska P. Changes in diet in Finland from 1972 to 1992: impact on coronary heart disease risk. Prev Med 1996; 25: 24350.
  • 23
    Ford ES, Mokdad AH, Giles WH, Mensah GA. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation 2003; 107: 21859.
  • 24
    WHO Expert Commitee. Prevention of coronary disease. Techn Rep Ser 1982; 678.
  • 25
    Blackburn H. Conference on the health effects of blood lipids: optimal distributions for populations. Prev Med 1979; 8: 61278.
  • 26
    Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143421.
  • 27
    Nicklas TA, Webber LS, Srinivasan SR, Berenson GS. Secular trends in dietary intakes and cardiovascular risk factors of 10-y-old children: the Bogalusa Heart Study (1973–1988). Am J Clin Nutr 1993; 57: 9307.
  • 28
    Freedman DS, Srinivasan SR, Valdez RA, Williamson DF, Berenson GS. Secular increases in relative weight and adiposity among children over two decades: the Bogalusa Heart Study. Pediatrics 1997; 99: 4206.
  • 29
    Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 22934.
  • 30
    Lakka H-M, Laaksonen DE, Lakka TA et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 270916.
  • 31
    Haffner S, Taegtmeyer H. Epidemic obesity and the metabolic syndrome. Circulation 2003; 108: 15415.
  • 32
    Pesonen E, Viikari J, Åkerblom HK, Räsänen L, Louhivuori K, Sarna S. Geographic origin of the family as a determinant of serum levels of lipids in Finnish children. Circulation 1986; 73: 111926.